Literature DB >> 3372160

Ocular toxoplasmosis in immunosuppressed nonhuman primates.

G N Holland1, G R O'Connor, R F Diaz, P Minasi, W M Wara.   

Abstract

To investigate the role of cellular immunodeficiency in recurrent toxoplasmic retinochoroiditis, six Cynomolgus monkeys (Macaca fascicularis) with healed toxoplasmic lesions of the retina were immunosuppressed by total lymphoid irradiation. Three months prior to irradiation 30,000 Toxoplasma gondii organisms of the Beverley strain had been inoculated onto the macula of eye in each monkey via a pars plana approach. Toxoplasmic retinochoroiditis developed in each animal, and lesions were allowed to heal without treatment. During total lymphoid irradiation animals received 2000 centigrays (cGy) over a 7-week period. Irradiation resulted in an immediate drop in total lymphocyte counts and decreased ability to stimulate lymphocytes by phytohemagglutinin. Weekly ophthalmoscopic examinations following irradiation failed to show evidence of recurrent ocular disease despite persistent immunodeficiency. Four months after irradiation live organisms were reinoculated onto the nasal retina of the same eye in each animal. Retinochoroidal lesions identical to those seen in primary disease developed in five of six animals. Toxoplasma organisms therefore were able to proliferate in ocular tissue following the administration of immunosuppressive therapy. This study fails to support the hypothesis that cellular immunodeficiency alone will initiate recurrent toxoplasmic retinochoroiditis. Results suggest that reactivation of disease from encysted organisms involves factors other than suppression of Toxoplasma proliferation. If reactivation occurs by other mechanisms, however, cellular immunodeficiency then may allow development of extensive disease.

Entities:  

Mesh:

Year:  1988        PMID: 3372160

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  The SAG1 Toxoplasma gondii surface protein is not required for acute ocular toxoplasmosis in mice.

Authors:  Elizabeth Charles; Michelle C Callegan; Ira J Blader
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

2.  Diffuse necrotizing retinochoroiditis in a child with AIDS and toxoplasmic encephalitis.

Authors:  F Bottoni; P Gonnella; A Autelitano; N Orzalesi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Interleukin-6-driven inflammatory response induces retinal pathology in a model of ocular toxoplasmosis reactivation.

Authors:  Élise Rochet; Julie Brunet; Marcela Sabou; Luc Marcellin; Tristan Bourcier; Ermanno Candolfi; Alexander W Pfaff
Journal:  Infect Immun       Date:  2015-03-09       Impact factor: 3.441

4.  Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy.

Authors:  Douglas A Jabs; Mark L Van Natta; Gary N Holland; Ronald Danis
Journal:  Am J Ophthalmol       Date:  2016-10-27       Impact factor: 5.258

Review 5.  Ocular toxoplasmosis in the immunocompromised host.

Authors:  G N Holland
Journal:  Int Ophthalmol       Date:  1989-12       Impact factor: 2.031

6.  Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice.

Authors:  M S Hu; J D Schwartzman; G R Yeaman; J Collins; R Seguin; I A Khan; L H Kasper
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

7.  Comparison of enzyme-linked immunosorbent assay, immunoblotting, and PCR for diagnosis of toxoplasmic chorioretinitis.

Authors:  Odile Villard; Denis Filisetti; Florence Roch-Deries; Justus Garweg; Jacques Flament; Ermanno Candolfi
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

8.  First report of Toxoplasma gondii seroprevalence in wild-caught Caribbean African green monkeys.

Authors:  Clare M Hamilton; Frank Katzer; Amy Beierschmitt; Esteban Soto; Elisabeth A Innes; Patrick J Kelly
Journal:  Parasit Vectors       Date:  2014-12-10       Impact factor: 3.876

Review 9.  Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches.

Authors:  Dimitrios Kalogeropoulos; Hercules Sakkas; Bashar Mohammed; Georgios Vartholomatos; Konstantinos Malamos; Sreekanth Sreekantam; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal:  Int Ophthalmol       Date:  2021-08-09       Impact factor: 2.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.